|
RPRX | Royalty Pharma Plc |
|
|
RPRX | Royalty Pharma Plc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.41 |
| Leverage | 50.27% |
| Market Cap | $ 23.7B |
| PE | 31.17 |
| Dividend Yield | 2.21% |
| Profit | $ 761.8m |
| Margin | 32.63% |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States. The company is headquartered in New York, New York.